Compare

Arjo AB/Skr ARJO B

1D1W1M3M6MYTD1Y5YMAX

About Arjo AB

Arjo AB is a Swedish company operating in the medical technology industry, specializing in products and solutions that improve the quality of life for patients with reduced mobility and age-related health challenges. The company's offerings include medical beds, patient transfer systems, hygiene systems, and pressure injury prevention products. Founded in 1957, Arjo has a long history in healthcare solutions and is headquartered in Malmö, Sweden. The company operates globally, with a significant presence in Europe, North America, and other regions. Arjo's competitive strength lies in its focus on enhancing patient outcomes and caregiver efficiency through innovative and ergonomic healthcare solutions.
Ticker
Skr ARJO B
Sector
Health
Primary listing
XSTO
Employees
7,000
Headquarters
Malmö, Sweden
Website
www.arjo.com

Arjo AB Metrics

BasicAdvanced
kr 9.2B
25.49
kr 1.33
0.69
kr 0.95
2.81%

What the Analysts think about Arjo AB

Analyst ratings (Buy, Hold, Sell) for Arjo AB stock.
Analyst projections of the future price of Arjo AB stock.

Bulls say / Bears say

Arjo accelerated to 6% organic sales growth in Q3 2026, from 3.8% a year earlier, with sales rising to SEK 2.85 billion. The stronger quarter suggests demand is improving across its markets. (Arjo)
Profitability improved sharply: Q3 gross margin rose to 43.0% from 41.1%, and adjusted operating profit increased to SEK 247 million from SEK 165 million. Operating cash flow also grew year on year to SEK 485 million. (Arjo)
Arjo has committed to improving EBIT by about SEK 350 million versus 2025 by mid-2029, through a simpler operating model, procurement savings and stronger commercial execution. If delivered, this could lift earnings without relying on sales growth. (Arjo)
Reported Q3 earnings weakened despite stronger adjusted operating profit: net profit fell to SEK 58 million from SEK 81 million, and EPS dropped to SEK 0.21 from SEK 0.30. A SEK 62 million revaluation charge on investments shows how financial items can add volatility to shareholder earnings. (Arjo)
The efficiency plan comes with about SEK 370 million of one-off investment, mostly expected by 2027, and Arjo reported higher restructuring costs in Q3. The savings depend on executing a broad organisational and procurement overhaul, so delays or disruption could weigh on returns. (Arjo, Arjo)
Some of Q3’s margin improvement relied on a US tariff reimbursement and favourable foreign exchange, while higher transport costs continued to offset gains. That makes it less certain that the full quarterly improvement will persist if these supports fade or costs rise. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 22 Oct 2026.

Arjo AB Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Arjo AB Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Arjo AB

Funds
Fund name
Fund size
Skr ARJO B weighting
Xtrackers MSCI Europe Small Cap£XXSC
$3.6B0.03%
Xtrackers MSCI Europe Small Cap€DX2J
$3.6B0.03%
iShares MSCI World Small Cap£WLDS
$9B0.01%
iShares MSCI World Small Cap$WSML
$9B0.01%
iShares MSCI World Small Cap€IUSN
$9B0.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.